HIV Mutation Detail Information

> T215D Search Result


Mutation Information
Mutation Site T215D
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Country Spain
Literature Information
PubMed PMID 32408111
Disease HIV infection/AIDS
Published Year 2020
Journal EBioMedicine
Title Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO).
Author De Miguel R,Rial-Crestelo D,Dominguez-Dominguez L,Montejano R,Esteban-Cantos A,Aranguren-Rivas P,Stella-Ascariz N,Bisbal O,Bermejo-Plaza L,Garcia-Alvarez M,Alejos B,Hernando A,Santacreu-Guerrero M,Cadiñanos J,Mayoral M,Castro JM,Moreno V,Martin-Carbonero L,Delgado R,Rubio R,Pulido F,Arribas JR,ART-PRO, PI16/00837-PI16/00678 study group.
Evidence Table 3

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation